This Training school is created to encourage the development and interaction of modeler’s and biologist’s communities by giving the opportunity to meet in Riga. We aim to give a stage to the developers and users of different systems biology and systems medicine modelling approaches to present their newest software, results and application examples.

More information and registration at:  


The following Speakers have confirmed participation:


Prof. Dr. Harald Schmidt

Chair of COST action OpenMultiMed

Head of Department of Pharmacology & Personalized Medicine, Maastricht University, The Netherlands

Research interests: Systems medicine, network pharmacology, drug repurposing


Prof. Egils Stalidzans

Computational Systems Biology group, University of Latvia Director of Institute of Microbiology and Biotechnology Latvia

Research interests: Kinetic and stoichiometric modeling of metabolism, modeling of pharmacokinetics, user of COPASI and COBRA


Iñigo Apaolaza

Department of Biomedical Engineering and Sciences, TECNUN School of Engineering, University of Navarra, Spain

Research interests: Systems Biology, Constraint-Based Modeling, drug target identification, user and developer of COBRA


Prof. Adil Mardinoglu

Systems Medicine group, King’s College London, UK and KTH-Royal Institute of Technology,      Sweden

Research interests: Systems Medicine, Integration of multi-omics using biological networks, Biomarker and drug target discovery, user/developer of RAVEN and user of COBRA


The course will be composed of sessions that will combine theory and hands-on lectures. Travel expenses reimbursement is possible for selected trainees through the CA15120 Cost Action.


Venue: Academic Center for Life Sciences, University of Latvia, Riga, Latvia

Time: August 11, 2019, at 12:30 to August 13,2019, at 12:30

Expected Numbers of Trainees: 20 students, postdocs or early stage researchers with basic training in medicine, network biology, modelling or relevant field

The course is organized by Institute of Microbiology and Biotechnology of University of Latvia and Open Multiscale Systems Medicine (OpenMultiMed) COST Action.